Healthcare / Medical Care FacilitiesXETRA
$3.94
+0.20 (+5.35%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $35.9M · quality 47.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$187M
P/E
5.3x
↓EV/EBITDA
5.1x
↓ROE
11.2%
↑Gross Margin
83.2%
↑Debt/Equity
2.09
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+3.6%
FCF CAGR
-18.0%
FCF margin
4.8%
FCF / Net income
1.44x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $748.8M · net income $24.8M · FCF $35.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $748.8M | $748.8M | $730.1M | $704.7M | $673.1M |
| Net Income | $24.8M | $24.8M | $-10.8M | $9.4M | $1.5M |
| EBITDA | $106.4M | $106.4M | $101.3M | $91.8M | $85.4M |
| EPS | 0.52 | 0.52 | -0.23 | 0.20 | 0.03 |
| Gross Margin | 83.2% | 83.2% | 81.4% | 81.1% | 81.9% |
| Operating Margin | 7.0% | 7.0% | 1.6% | 2.6% | 1.6% |
| Net Margin | 3.3% | 3.3% | -1.5% | 1.3% | 0.2% |
| Balance Sheet | |||||
| Debt/Equity | 2.09 | 2.09 | 2.45 | 2.40 | 2.40 |
| Current Ratio | 1.74 | 1.74 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $35.9M | $35.9M | $40.4M | $8.6M | $65.0M |
| Returns | |||||
| ROE | 11.2% | 11.2% | -5.5% | 4.5% | 0.8% |
| Valuation | |||||
| P/E | 5.32 | 5.32 | — | 16.80 | 126.67 |
| EV/EBITDA | 5.11 | 5.11 | 4.87 | 6.25 | 5.86 |
| P/B | 0.84 | 0.84 | 0.65 | 0.76 | 0.98 |
| Growth & Yield | |||||
| Revenue Growth | 2.6% | 2.6% | 3.6% | 4.7% | — |
| EPS Growth | 326.1% | 326.1% | -215.0% | 566.7% | — |
| Dividend Yield | 1.1% | 1.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-12.4%
EPS terminal req.
$0.35
Spread vs growth
338.5%
5Y implied EPS CAGR
-4.0%
EPS terminal req.
$0.42
Spread vs growth
330.1%
10Y implied EPS CAGR
2.7%
EPS terminal req.
$0.68
Spread vs growth
323.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+34.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.23 → 0.52
Residual
+33.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.